Model: C57/B6 female mice
Dosage: 300 mg/kg of ꞵ-hydroxybutyrate intraperitoneally injected three times per week for four weeks

Intermittent Fasting Potently Suppresses Tumor Growth: New Study Findings

Researchers show that intermittent fasting — going without food for 16-hour intervals per day — reduces tumor growth and extends lifespan in mice with ovarian cancer.

(A mouse with an ovarian tumor next to a dish of food in a laboratory | NAD.com)

Intermittent fasting significantly extends remaining lifespan and suppresses tumor growth in mice with an aggressive and lethal form of ovarian cancer.

Cancer

Model: Male C57BL/6 mice
Dosage: 400 mg/kg/day by oral gavage for 21 days starting at eight weeks after ionizing radiation exposure

NAD+ Precursor NR Reduces Side Effects of Anticancer Radiation Therapy: New Study

Researchers show nicotinamide riboside (NR) restores exercise capacity, increases white and red blood cells, and alleviates stem cell senescence in prematurely aged mice exposed to radiation for treating cancer.

(An aged mouse undergoing ionizing radiation cancer therapy | NAD.com)

NR restores physical function, increases blood cell counts, and reduces bone marrow stem cell senescence in mice exposed to ionizing radiation.

NAD Precursor NR Reduces Side Effects of Anticancer Radiation Therapy, Reveals New Study

Model: NOD/SCID mice
Dosage: 3.4 mg/kg/day of neopetroside-B injected for three consecutive days

NAD+ Boosting Neopetroside-B Protects the Heart and Suppresses Cancer

Researchers show treatment with the nicotinamide adenine dinucleotide (NAD+) precursor neopetroside-B increases heart cell survival, prevents chemotherapy-induced heart scarring, and reduces tumor volume in mice.

(The molecular structure of the NAD+ precursor neopetroside-B)

Discover groundbreaking findings from a Korean study on Neopetroside-B's remarkable role in safeguarding the heart during chemotherapy while also exhibiting cancer-suppressing properties. Learn how NAD augmentation holds promise for enhanced cancer treatments.

NAD Boosting Neopetroside-B: Protecting the Heart during Chemotherapy & Suppressing Cancer – Korean Study

Model: Terminally-ill humans with treatment-resistant cancer
Dosage: 20, 40, or 60 mg/m2 of ATX-101 injected weekly via infusion for six weeks

Breakthrough New Drug Can Stop Multiple Cancer Types: Australian Study

High percentages of terminally ill and treatment-resistant cancer patients show stopped tumor growth following ATX-101 treatment.

(One of ATX-101’s key developers, Marit Otterlei)

A new drug stops tumor growth in 70% of patients with treatment-resistant cancer types that render them terminally ill by targeting a protein that helps cancer cells survive stress.

Model: C57BL/6N or BALB/c mice 
Dosage: 2 mg/kg of spermidine by intraperitoneal injection

Kyoto University researchers find spermidine inhibits tumor growth in mice by improving the mitochondrial function of anticancer immune cells.

(The study’s principal investigator, Dr. Tasuku Honjo | Japan Times)

Search Result: Anticancer Therapy

Intermittent Fasting Potently Suppresses Tumor Growth to Prolong Survival: New Study Findings

NAD⁺ Precursor NR Reduces Side Effects of Anticancer Radiation Therapy: New Study

NAD⁺ Boosting Molecule Protects the Heart Against Chemotherapy and Suppresses Cancer: Korean Study

Breakthrough New Drug Can Stop Multiple Cancer Types: Australian Study

Japanese Study Suggests Spermidine Enhances Immunity Against Cancer